{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T18:37:46Z","timestamp":1789843066499,"version":"4.0.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.jneuroim.2016.01.020","type":"journal-article","created":{"date-parts":[[2016,2,4]],"date-time":"2016-02-04T13:46:56Z","timestamp":1454593616000},"page":"97-101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["The role of dopamine in modulation of Th-17 immune response in multiple sclerosis"],"prefix":"10.1016","volume":"292","author":[{"given":"Mikhail","family":"Melnikov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Belousova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Murugin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u041cikhail","family":"Pashenkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexey","family":"Boy\u043a\u043e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jneuroim.2016.01.020_bb0005","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000323953","article-title":"Stress as a risk factor for multiple sclerosis onset or relapse: a systematic review","volume":"36","author":"Artemiadis","year":"2011","journal-title":"Neuroepidemiology"},{"issue":"4","key":"10.1016\/j.jneuroim.2016.01.020_bb0010","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1093\/arclin\/acs039","article-title":"Stress management and multiple sclerosis: a randomized controlled trial","volume":"27","author":"Artemiadis","year":"2012","journal-title":"Arch. Clin. Neuropsychol."},{"issue":"12","key":"10.1016\/j.jneuroim.2016.01.020_bb0015","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/j.jocn.2013.01.018","article-title":"Cigarette smoking and associated risk of multiple sclerosis in the Iranian population","volume":"20","author":"Asadollahi","year":"2013","journal-title":"J. Clin. Neurosci."},{"issue":"2","key":"10.1016\/j.jneuroim.2016.01.020_bb0020","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0165-5728(99)00176-9","article-title":"Dopamine, a neurotransmitter, influences the immune system","volume":"102","author":"Basu","year":"2000","journal-title":"J. Neuroimmunol."},{"issue":"11","key":"10.1016\/j.jneuroim.2016.01.020_bb0025","doi-asserted-by":"crossref","first-page":"5438","DOI":"10.4049\/jimmunol.1103801","article-title":"Human Th17 cells express high levels of enzymatically active dipeptidylpeptidase IV (CD26)","volume":"188","author":"Bengsch","year":"2012","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.jneuroim.2016.01.020_bb0030","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1002\/elps.1150181009","article-title":"Measurements of catecholamine-mediated apoptosis of immunocompetent cells by capillary electrophoresis","volume":"18","author":"Bergquist","year":"1997","journal-title":"Electrophoresis"},{"issue":"1","key":"10.1016\/j.jneuroim.2016.01.020_bb0035","doi-asserted-by":"crossref","first-page":"679","DOI":"10.4049\/jimmunol.1000366","article-title":"Human Th17 cells comprise heterogeneous subsets including IFN-gamma-producing cells with distinct properties from the Th1 lineage","volume":"185","author":"Boniface","year":"2010","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.jneuroim.2016.01.020_bb0040","first-page":"89","article-title":"Evaluation of CD4+CD161+CD196+ and CD4+IL-17+ Th17 cells in the peripheral blood of young patients with Hashimoto's thyroiditis and Graves' disease","volume":"18","author":"Bossowski","year":"2012","journal-title":"Pediatr. Endocrinol. Diabetes Metab."},{"key":"10.1016\/j.jneuroim.2016.01.020_bb0045","article-title":"Smoking and risk of multiple sclerosis: evidence of modification by NAT1 variants","volume":"12","author":"Briggs","year":"2014","journal-title":"Epidemiology"},{"issue":"1\u20132","key":"10.1016\/j.jneuroim.2016.01.020_bb0050","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0165-5728(03)00047-X","article-title":"In vivo administration of L-dopa or dopamine decreases the number of splenic IFN gamma-producing cells","volume":"137","author":"Carr","year":"2003","journal-title":"J. Neuroimmunol."},{"issue":"5","key":"10.1016\/j.jneuroim.2016.01.020_bb0055","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/ana.21652","article-title":"T-helper 17 cells expand in multiple sclerosis and are inhibited by interferon-beta","volume":"65","author":"Durelli","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2016.01.020_bb0060","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.bbi.2014.05.013","article-title":"Dopamine favors expansion of glucocorticoid-resistant IL-17-producing T cells in multiple sclerosis","volume":"41","author":"Ferreira","year":"2014","journal-title":"Brain Behav. Immun."},{"issue":"7","key":"10.1016\/j.jneuroim.2016.01.020_bb0065","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/S1567-5769(03)00100-0","article-title":"Dopamine inhibits cytokine release and expression of tyrosine kinases, Lck and Fyn in activated T cells","volume":"3","author":"Ghosh","year":"2003","journal-title":"Int. Immunopharmacol."},{"issue":"7","key":"10.1016\/j.jneuroim.2016.01.020_bb0070","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1089\/jir.2005.25.395","article-title":"Dopamine fails to regulate activation of peripheral blood lymphocytes from multiple sclerosis patients: effects of IFN-beta","volume":"25","author":"Giorelli","year":"2005","journal-title":"J. Interf. Cytokine Res."},{"issue":"4","key":"10.1016\/j.jneuroim.2016.01.020_bb0075","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.bbrc.2009.04.034","article-title":"Dopamine D1-like receptor antagonist, SCH23390, exhibits a preventive effect on diabetes mellitus that occurs naturally in NOD mice","volume":"383","author":"Hashimoto","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"11","key":"10.1016\/j.jneuroim.2016.01.020_bb0080","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s10654-013-9853-4","article-title":"Smoking and multiple sclerosis susceptibility","volume":"28","author":"Hedstr\u00f6m","year":"2013","journal-title":"Eur. J. Epidemiol."},{"issue":"4","key":"10.1016\/j.jneuroim.2016.01.020_bb0085","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/00006842-199307000-00004","article-title":"Stress and immunity in humans: a meta-analytic review","volume":"55","author":"Herbert","year":"1993","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.jneuroim.2016.01.020_bb0090","first-page":"492","article-title":"Th17 cells in the pathogenesis of multiple sclerosis","volume":"63","author":"Juszczak","year":"2009","journal-title":"Postepy Hig. Med. Dosw. (Online)"},{"issue":"9585","key":"10.1016\/j.jneuroim.2016.01.020_bb0095","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0140-6736(07)61194-5","article-title":"Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study","volume":"370","author":"Kappos","year":"2007","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.jneuroim.2016.01.020_bb0100","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.autrev.2013.02.006","article-title":"Effect of stress on brain inflammation and multiple sclerosis","volume":"12","author":"Karagkouni","year":"2013","journal-title":"Autoimmun. Rev."},{"issue":"11","key":"10.1016\/j.jneuroim.2016.01.020_bb0105","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.jneuroim.2016.01.020_bb0110","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.immuni.2008.11.005","article-title":"Late developmental plasticity in the T helper 17 lineage","volume":"30","author":"Lee","year":"2009","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.jneuroim.2016.01.020_bb0115","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.coph.2008.05.001","article-title":"Neurotransmitters activate T-cells and elicit crucial functions via neurotransmitter receptors","volume":"8","author":"Levite","year":"2008","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.jneuroim.2016.01.020_bb0120","article-title":"Dopamine and T cells: dopamine receptors and potent effects on T cells, dopamine production in T cells, and abnormalities in the dopaminergic system in T cells in autoimmune, neurological and psychiatric diseases","author":"Levite","year":"2015","journal-title":"Acta Physiol. (Oxf.)"},{"issue":"3","key":"10.1016\/j.jneuroim.2016.01.020_bb0125","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1159\/000226428","article-title":"Relationship between psychosocial factors and onset of multiple sclerosis","volume":"62","author":"Liu","year":"2009","journal-title":"Eur. Neurol."},{"issue":"6","key":"10.1016\/j.jneuroim.2016.01.020_bb0130","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1177\/1352458506073482","article-title":"Patient, information and coping styles in multiple sclerosis","volume":"13","author":"Lode","year":"2007","journal-title":"Mult. Scler."},{"issue":"5","key":"10.1016\/j.jneuroim.2016.01.020_bb0135","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1177\/1352458509102313","article-title":"Depressive symptoms and coping in newly diagnosed patients with multiple sclerosis","volume":"15","author":"Lode","year":"2009","journal-title":"Mult. Scler."},{"issue":"11","key":"10.1016\/j.jneuroim.2016.01.020_bb0140","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s11910-013-0398-4","article-title":"Stress in multiple sclerosis: review of new developments and future directions","volume":"13","author":"Lovera","year":"2013","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.jneuroim.2016.01.020_bb0145","series-title":"Molecular Basis of Multiple Sclerosis","first-page":"75","author":"Martin","year":"2010"},{"issue":"3","key":"10.1016\/j.jneuroim.2016.01.020_bb0150","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/00207450802480192","article-title":"The effects of stressful life events on the course of multiple sclerosis: a review","volume":"119","author":"Mitsonis","year":"2009","journal-title":"Int. J. Neurosci."},{"issue":"5","key":"10.1016\/j.jneuroim.2016.01.020_bb0155","first-page":"803","article-title":"Moderating effects of coping on the relationship between stress and the development of new brain lesions in multiple sclerosis","volume":"64","author":"Mohr","year":"2002","journal-title":"Psychosom. Med."},{"issue":"2","key":"10.1016\/j.jneuroim.2016.01.020_bb0160","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.bbrc.2008.06.012","article-title":"Antagonizing dopamine D1-like receptor inhibits Th17 cell differentiation: preventive and therapeutic effects on experimental autoimmune encephalomyelitis","volume":"373","author":"Nakano","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.jneuroim.2016.01.020_bb0165","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1159\/000225902","article-title":"D1-like receptor antagonist inhibits IL-17 expression and attenuates crescent formation in nephrotoxic serum nephritis","volume":"30","author":"Okada","year":"2009","journal-title":"Am. J. Nephrol."},{"issue":"2 Pt 2","key":"10.1016\/j.jneuroim.2016.01.020_bb0170","first-page":"34","article-title":"The role of dopamine in the regulation of the interaction between nervous and immune systems in multiple sclerosis","volume":"112","author":"Orlova","year":"2012","journal-title":"Zh. Nevrol. Psikhiatr. Im. S. S. Korsakova"},{"issue":"2","key":"10.1016\/j.jneuroim.2016.01.020_bb0175","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s10880-012-9323-2","article-title":"Prevalence and significant determinants of post-traumatic stress disorder in a large sample of patients with multiple sclerosis","volume":"20","author":"Ostacoli","year":"2013","journal-title":"J. Clin. Psychol. Med. Settings"},{"issue":"Suppl. 1","key":"10.1016\/j.jneuroim.2016.01.020_bb0180","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/j.clineuro.2013.09.014","article-title":"Profile of depression, experienced distress and capacity for coping with stress in multiple sclerosis patients \u2014 a different perspective","volume":"115","author":"Ozura","year":"2013","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"1\u20132","key":"10.1016\/j.jneuroim.2016.01.020_bb0185","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jneuroim.2009.07.018","article-title":"Role of dopamine in the physiology of T-cells and dendritic cells","volume":"216","author":"Pacheco","year":"2009","journal-title":"J. Neuroimmunol."},{"issue":"2","key":"10.1016\/j.jneuroim.2016.01.020_bb0190","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann. Neurol."},{"issue":"7","key":"10.1016\/j.jneuroim.2016.01.020_bb0195","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/S1567-5769(01)00068-6","article-title":"Circulating dopamine level, in lung carcinoma patients, inhibits proliferation and cytotoxicity of CD4+ and CD8+ T cells by D1 dopamine receptors: an in vitro analysis","volume":"1","author":"Saha","year":"2001","journal-title":"Int. Immunopharmacol."},{"issue":"2","key":"10.1016\/j.jneuroim.2016.01.020_bb0200","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.mehy.2012.11.016","article-title":"Stress caused adverse entanglement of the nervous and autoimmune systems: a case for MS","volume":"80","author":"Schad","year":"2013","journal-title":"Med. Hypotheses"},{"issue":"36","key":"10.1016\/j.jneuroim.2016.01.020_bb0205","doi-asserted-by":"crossref","first-page":"5837","DOI":"10.2174\/138161212803523671","article-title":"Stress, depression and antidepressant treatment options in patients suffering from multiple sclerosis","volume":"18","author":"Schumann","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jneuroim.2016.01.020_bb0210","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.bbi.2012.12.015","article-title":"Chronic mild stress eliminates the neuroprotective effect of Copaxone after CNS injury","volume":"31","author":"Smirnov","year":"2013","journal-title":"Brain Behav. Immun."},{"issue":"4","key":"10.1016\/j.jneuroim.2016.01.020_bb0215","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1177\/1352458509358714","article-title":"Patients with multiple sclerosis in a war zone: coping strategies associated with reduced risk for relapse","volume":"16","author":"Somer","year":"2010","journal-title":"Mult. Scler."},{"issue":"2","key":"10.1016\/j.jneuroim.2016.01.020_bb0220","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1177\/1099800411425703","article-title":"Psychological stress and cytokine production in multiple sclerosis: correlation with disease symptomatology","volume":"15","author":"Sorenson","year":"2013","journal-title":"Biol. Res. Nurs."},{"issue":"1","key":"10.1016\/j.jneuroim.2016.01.020_bb0225","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0149-7634(99)00063-9","article-title":"Structure and function of dopamine receptors","volume":"24","author":"Vallone","year":"2000","journal-title":"Neurosci. Biobehav. Rev."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572816300200?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572816300200?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:27:35Z","timestamp":1759048055000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572816300200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":45,"alternative-id":["S0165572816300200"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2016.01.020","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of dopamine in modulation of Th-17 immune response in multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2016.01.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}